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ABSTRACT
Genome-Wide-Association-Studies have become
a powerful method to link point mutations (e.g.
single nucleotide polymorphisms (SNPs)) to a certain
phenotype or a disease. However, their power to
detect SNPs associated to polygenic diseases such
as Alzheimer’s Disease (AD) is limited, since they can
only infer the pairwise relation of single SNPs to the
phenotype and ignore possible effects of various SNP
combinations. The common method to probe these
possible complex genetic patterns is to compute a
measure called linkage disequilibrium (LD). Despite
the fact that several predictive patterns found with LD
could successfully be applied to medical diagnosis, this
measure still holds several drawbacks as for example
the difficulty to confirm and replicate experimental
results as well as its sensitivity to statistical biases.
Here, we present the application of an alternative
method, Linkage Probability (LP) for genetic pattern
identification that provides the posterior probability
of a relation between two categorical data sets and
simultaneously considers potential biases from latent
variables, such as the recombination rate or the genetic
structure of a population. By applying the LP framework
to data from the ADSP-Project, we show that changes
of linkage patterns between SNPs can be associated
to Alzheimer’s disease. Common genomic relation
measures still fail to extract this link.
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INTRODUCTION
Aging populations are associated with a higher
propensity for neurodegenerative diseases such as
Alzheimer’s disease (AD), the most common form of
dementia. In only 1 to 5% of the cases, AD can
be significantly traced back to dominantly inherited
mutations in the APP and/or PS1/2 gene [1], but in
most cases, except of the ApoE Gene [2, 3], AD only
shows a weak genetic background while its causes still
remain unknown. From all so-far known risk-factors
age is usually considered to be the strongest predictor
of AD. 30% of today’s population develop AD beyond
the age of 85 [4]. Furthermore, several risk factors
related to lifestyle such as physical fitness, smoking
status and body weight have been intensively studied
and brought into the context of AD-risk [5, 6]. In terms of
genetics, the APOE ε4 allele has a significantly-higher
relative frequency in populations with AD [7] compared
to healthy people. Besides, various other single
nucleotide polymorphisms located in the genes APOE
CLU, PICALM, EPHA1 and FERMT2 have been linked
to AD [8–10].
Within the recent decade, Genome-wide association
studies (GWAS) [8, 9, 11] became increasingly important
in unravelling the genetics of diseases and complex
traits by identifying genetic variants and linking them
to specific phenotypes via statistical tests. Regardless
of scientific advances, this methodology is unable to
detect complex patterns such as SNP clusters to explain
multifactorial diseases such as AD.
Associations among SNPs are commonly detected
using simple metrics such as a linkage disequilibrium
(LD) [12, 13]. LD is defined as the non-random
pairwise association between alleles at different gene
loci [14]. Nevertheless, there are many latent factors
that can influence LD: the recombination rate, the
genetic structure of the population and the rate of
mutations. Since these latent factors are not always
known for the data to be analysed, like e.g. the
genetic background or kinship of the subjects, LD values
are usually biased, thus potentially leading to wrong
interpretation of results. Despite these drawbacks, LD
is still widely used in high profile studies, aside from
other methodologies using frequencies or contingency
tables to compute pairwise SNP-SNP relations [15,
16]. In order to take into account these potential
latent factors, we applied a new method [17] that
computes the linkage probability (LP) of a pairwise
relation between two SNPs. The complete framework
can be downloaded in form of a MATLAB toolbox
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at https://github.com/SusanneGerber/PRP-Measure-MATLAB
together with an extensive user manual. This method
- based on [17–22] - allows to circumvent the typical
biases that might become imposed by the common LD
measure.
Due to the polygenic nature of AD, genetic factors
underlying the onset of AD cannot be explained by
one-dimensional models [23]. Applying instead a
measure such as LP to uncover unbiased clusters of
variants each associated with AD gives an opportunity
to extract and analyse complex underlying networks.
METHODS
Whole-exome sequencing data were obtained from
the Alzheimer’s Disease Sequencing Project (ADSP)
[Study report]. With a permission from NIH, data were
retrieved directly from the dbGaP website (dbGaP Study
Accession: phs000572.v7.p4). The dataset contains
genotypes and phenotype information of 679 patients
suffering from late onset AD and of 90 Polymorphisms
control subjects.
First, we performed a standard GWAS to extract
significant SNPs lying in (or in a close vicinity to) the
genes already reported to be associated with AD in
previous studies [4, 8, 9, 11]. Afterwards, we divided the
available SNPs from the ADSP-dataset into two groups.
The first group contains all those SNPs that are part of
the aforementioned genes associated to AD (n=1070)
whereas the second group contains all the remaining
SNPs (n=1390369). This knowledge-driven preselection
was performed due to the time-consuming nature of
computing multivariate associations. The genetic data
were downloaded as VCF files and converted into
the PLINK binary format BED. We used the Fisher’s
exact test to calculate odds ratios and p-values (PLINK
1.9) [14]. The Manhattan plot generated to visualize the
output of the GWAS was produced using the "qqman" -
package in R 3.2.3.
A mathematical framework to analyse genetic data
taking latent variables into account
The LP-measure differs from the standard measures
for computing pairwise relations between categorical
variables mainly in two ways:
1. LP provides the posterior probability of a relation
between two categorical data sets and is able to consider
an eventual bias coming from latent variables
2. Since LP provides a direct estimate of the
posterior probability of a relation conditioned on
the given data it does not introduce an additional
model error that results from the mathematical effects
such as scaling/transformation-dependence of variables,
stationarity assumptions or others.
For further details we refer to the original
publication [17].
Figure 1: Manhattan Plot of 1.391.439 SNPs from 679
Individuals. p-values were obtained by performing the
Fisher’s exact test with PLINK 1.9. The vertical axis displays
the p-values transformed with the formula -log10(p) and the
horizontal axis contains the SNP positions on the genome. The
green marked SNPs are SNPs that have been already reported
to be associated with AD.
RESULTS
Analysing p-values and computing the Linkage
Probability Measure
We calculated the p-values of the Fisher’s exact test
for all 1391439 SNPs (related or non-related to AD)
from 769 individuals and visualized them by means of
a Manhattan plot (Figure 1). Out of the whole dataset,
only a well-known variant of the APOE gene (rs429358)
showed a significant p-value below 5×10−12 [15, 16]. (T)
is the common allele of rs429358. The APOE ε4 allele is
formed when both rs429358 C and the rs7412 (C) alleles
are present. Another interesting candidate we found,
called rs11556505, is also known to be associated with
AD [16, 17].
We then performed analysis of linkage. One problem
of LD is that it is difficult to interpret due to missing
objective criteria regarding the relevance of the particular
SNP association. Ranking SNP associations is usually
carried out by examining the function of associated
genes as a possible evidence for significance. As a
possibly more objective criterion, we decided to separate
the SNPs that are strongly related to AD from others,
and study how the linkage patterns change between
SNPs from genes associated to AD and genes which
have not been reported to have an association to the
disease. In our hypothesis, patterns associated to AD
should emerge only from SNPs related to AD.
To elaborate on this, we created two samples:
considering the runtime for computation, we chose one
sample containing the 1000 SNPs which exhibit the
strongest association (p < 0.01) to AD and a second
sample containing 1000 SNPs with no relation to AD
using the results from the Fisher’s exact test. In order
to examine the associations within these two samples,
we computed LP and for comparison LD in both cases
(Figure 2, Figure 3).
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Figure 2: Linkage Probability for 1000 SNPs associated to AD (2A and 2C) and 1000 SNPs which are not associated to
AD (2B and 2D). SNPs were selected based on their p-value from the Fisher’s exact test. LP was computed for 679 cases (top
left/right) and for 90 controls (bottom left/right). A pair is a (i,j) couple with i and j being the indices of the 1000 SNPs. On the map,
the first SNP for i (vertical axis) is on the top and the first SNP for j (horizontal axis) is on the left. Values for a SNP with itself
correspond to the values in the diagonal.
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Figure 3: Disequilibrium for 1000 SNPs associated to AD (3A and 3C) and 1000 SNPs which are not associated to AD (3B
and 3D). SNPs were chosen by p-value from the Fisher’s exact test. LD was computed for 679 cases (top left/right) and for 90
controls (bottom left/right). A pair is a (i,j) couple with i and j being the indices of the 1000 SNPs. On the map, the first SNP for
i (vertical axis) is on the top and the first SNP for j (horizontal axis) is on the left. Values for a SNP with itself correspond to the
values in the diagonal.
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Overall, the patterns of association appear to be
similar in LP and LD for SNPs associated to the disease,
as well as SNPs which have not been reported to have
an association. For both LP and LD, more associations
can be detected in the cohort of control subjects than
in the cohort of AD-cases. This phenomenon could be
partially explained by the differences in sample sizes
(679 cases, 90 controls). Since we wanted to keep
as much information as possible, we used the whole
cohort for calculation. To what extent the sample size
affects the outcome can be seen in Figure 5. The SNP
patterns hold also true for a sample size of 90 cases.
Furthermore, we found more associations between the
top associated SNPs in the control group than in AD
patients and less associations for SNPs which already
had been interpreted as exhibiting "no association" in
the Fisher’s exact test. This result holds true for both,
controls and AD patients. Despite the similar patterns
in LD and LP, the Linkage Probability measure tends to
find a larger number of SNPs with a high probability of
linkage as compared to the LD method (Figure 4) and so
is more discriminative.
Monitoring linkage disequilibrium dynamics using
the Linkage Probability framework
We hypothesize that differences in linkage patterns
between cases and controls could be derived from the
fact that there is a certain linkage disequilibrium in
healthy people, which might be disrupted by mutations in
people with AD - leading to less linkage between specific
SNP pairs. Therefore, people with AD will have less
associations between any SNP pair typically occurring
in the disease compared to healthy people.
Our results suggest such a conjecture. In Figure 2,
we can see that the linkage patterns captured by the LP
seem to vanish in patients suffering from AD (Figure 2
A&B), whereas healthy people have more complex LP
relation patterns (Figure 2 C&D). This applies to SNPs
associated with the disease, as well as for SNPs without
association. LD is more difficult to capture (Figure 3),
since we cannot see such clear trends as in the case
of LP. Nevertheless, LD scores seem to show more
erratic trends, hinting that high LP scores are better at
capturing meaningful disease-related associations than
LD (Figure 3).
To conclude, our results show that LP captures
more significant pairwise SNP-SNP-relations than LD
with a good agreement in terms of intersection for LD
values found by LP (see Figure 6), tending to show
that these SNPs are more representative. Moreover,
we hypothesize that the occurrence of some SNPs
associated with AD may disrupt linkage patterns of
SNPs in people suffering from AD in comparison to
the control group. In order to validate such an
hypothesis, one would require more investigations and
verifications to prove if our results still hold true with other
datasets and larger cohorts. Furthermore, the detected
discriminative patterns of pairwise SNP-SNP-relations
in cases and controls should be related to biological
functionality to confirm biological meaning. As a follow
up study, systematically investigate the relation between
the pattern of LP relations observed for AD (see Figure 1
and Figure 2) and the steric effects of mutations (e.g.,
captured by the Hi-C) to probe their possible involvement
in disturbing linkage disequilibrium. We also intend to
examine whether this finding can be generalized to other
types of neurodegenerative diseases.
A subsequent multistage model integrating different
layers of data such as transcription, protein structure
and interactions between genes or metabolic pathways
could provide further functional explanations for the
involvement of these genetics patterns in AD [24, 25].
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Figure 4: Distribution of LP and LD scores for genes associated to Alzheimer’s disease and control patients.. 4A.
Distribution of LP and LD for the 1000 SNPs with the strongest association to AD (smallest p-value in the Fisher’s exact test).
4B. Distribution of LP and LD scores for the mean of five randomly-picked samples (n= 1000 SNP), which had a p-value of 1 in
the Fisher-test, id est showed no association to AD.
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Figure 5: Linkage Probability for 1000 SNPs associated to AD (A) and 1000 SNPs which are not associated to AD (B).
SNPs were selected based on their p-value from the exact Fisher test. LP was computed for 90 cases (A) and for 90 controls (B).
A pair is a (i,j) couple with i and j being the indices of the 1000 SNPs. On the map, the first SNP for i (vertical axis) is on the top
and the first SNP for j (horizontal axis) is on the left. Values for a SNP with itself correspond to the values in the diagonal.
Figure 6: Pie-charts showing the percentage of captured
LD & LP association scores and the intersection between
them. 6A, 6B. Distribution of association scores for cases in
SNPs associated to AD. 6B. Distribution of association scores
for controls in SNPs associated to AD. 6C. Distribution of
association scores for cases in SNPs not associated to AD.
6D. Distribution of association scores for controls in SNP not
associated to AD.
LP: Linkage Probability
LD: Linkage Disequilibrium
ND: neurodegenerative disease
SNP: Single Nucleotide Polymorphism
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